1. Home
  2. EHTH vs LTRN Comparison

EHTH vs LTRN Comparison

Compare EHTH & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EHTH

eHealth Inc.

HOLD

Current Price

$1.47

Market Cap

52.4M

Sector

Finance

ML Signal

HOLD

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$4.07

Market Cap

46.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EHTH
LTRN
Founded
1997
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.4M
46.8M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
EHTH
LTRN
Price
$1.47
$4.07
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$3.33
N/A
AVG Volume (30 Days)
491.6K
202.3K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
18.65
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$1.11
52 Week High
$5.89
$5.74

Technical Indicators

Market Signals
Indicator
EHTH
LTRN
Relative Strength Index (RSI) 40.02 61.85
Support Level $1.43 $3.09
Resistance Level $1.58 $4.20
Average True Range (ATR) 0.14 0.34
MACD -0.02 -0.04
Stochastic Oscillator 9.20 83.09

Price Performance

Historical Comparison
EHTH
LTRN

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: